Related Experiment Video
Updated: Jun 6, 2026
09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Novel reduction-sensitive micelles for triggered intracellular drug release
Peijian Sun1, Danhua Zhou, Zhihua Gan
1CAS Key Laboratory of Engineering Plastics, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Summary
Novel reduction-sensitive micelles were developed for targeted drug delivery. These micelles efficiently release drugs inside cells under specific conditions, enhancing anticancer efficacy.
Area of Science:
- Polymer Chemistry
- Nanotechnology
- Biomedical Engineering
Background:
- Developing stimuli-responsive drug delivery systems is crucial for targeted therapy.
- Micelles offer a promising platform for encapsulating and delivering therapeutic agents.
- Intracellular drug release requires systems that can respond to the unique cellular environment.
Purpose of the Study:
- To synthesize and characterize novel reduction-sensitive micelles based on poly(ethylene oxide)-b-poly(N-methacryloyl-N'-(t-butyloxycarbonyl)cystamine) (PEO-b-PMABC) diblock copolymers.
- To evaluate the triggered intracellular drug release capabilities of these micelles.
- To assess the enhanced anticancer efficacy of drug-loaded PEO-b-PMABC micelles.
Main Methods:
- Synthesis of PEO-b-PMABC diblock copolymers using reversible addition-fragmentation chain transfer (RAFT) polymerization.
- Characterization of copolymers using gel permeation chromatography (GPC) and 1H NMR.
- Self-assembly of copolymers into micelles and investigation of their physicochemical properties using fluorescence spectroscopy, transmission electron microscopy (TEM), and dynamic light scattering (DLS).
- In vitro drug release studies and cell experiments with doxorubicin (DOX).
Main Results:
- PEO-b-PMABC diblock copolymers with controlled molecular weights and compositions were successfully synthesized.
- The copolymers self-assembled into stable micelles that are sensitive to reducing environments.
- Micelles demonstrated rapid cleavage and drug release under reducing conditions.
- Drug-loaded micelles exhibited significantly higher anticancer efficacy compared to non-sensitive controls.
Conclusions:
- Novel reduction-sensitive PEO-b-PMABC micelles are effective for triggered intracellular drug delivery.
- These micelles show great potential for enhancing the efficacy of anticancer therapeutics.
- The reduction-sensitive nature of the micelles enables efficient drug release within the cellular environment.
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...